- Home
- SVV vs SANA Comparison
SVV vs SANA Comparison
Compare SVV & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVV | SANA |
|---|---|---|
| Founded | 1954 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SVV | SANA |
|---|---|---|
| Price | $9.48 | $3.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $13.67 | $7.80 |
| AVG Volume (30 Days) | 1.3M | ★ 4.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,678,954,000.00 | N/A |
| Revenue This Year | $6.91 | N/A |
| Revenue Next Year | $7.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.19 | N/A |
| 52 Week Low | $6.91 | $2.26 |
| 52 Week High | $13.89 | $6.55 |
Technical Indicators
Market Signals| Indicator | SVV | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 44.61 |
| Support Level | $9.03 | $3.01 |
| Resistance Level | $9.98 | $3.43 |
| Average True Range (ATR) | 0.41 | 0.19 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 99.43 | 44.09 |
Price Performance
Historical ComparisonAbout SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.